| Angiotensin II for the treatment of vasodilatory shock A Khanna, SW English, XS Wang, K Ham, J Tumlin, H Szerlip, LW Busse, ... New England Journal of Medicine 377 (5), 419-430, 2017 | 791 | 2017 |
| Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin’s lymphomas MS Kaminski, AD Zelenetz, OW Press, M Saleh, J Leonard, ... Journal of clinical oncology 19 (19), 3918-3928, 2001 | 716 | 2001 |
| Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the … MS Kaminski, J Estes, KR Zasadny, IR Francis, CW Ross, M Tuck, ... Blood, The Journal of the American Society of Hematology 96 (4), 1259-1266, 2000 | 653 | 2000 |
| 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo G Maschek, N Savaraj, W Priebe, P Braunschweiger, K Hamilton, ... Cancer research 64 (1), 31-34, 2004 | 566 | 2004 |
| Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin’s lymphomas JM Vose, RL Wahl, M Saleh, AZ Rohatiner, SJ Knox, JA Radford, ... Journal of clinical oncology 18 (6), 1316-1323, 2000 | 441 | 2000 |
| In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits LC Griffin, GF Tidmarsh, LC Bock, JJ Toole, LL Leung | 375 | 1993 |
| Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule CA Whitlock, GF Tidmarsh, C Muller-Sieburg, IL Weissman Cell 48 (6), 1009-1021, 1987 | 318 | 1987 |
| Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II JA Tumlin, R Murugan, AM Deane, M Ostermann, LW Busse, KR Ham, ... Critical care medicine 46 (6), 949-957, 2018 | 227 | 2018 |
| Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma JP Leonard, M Coleman, L Kostakoglu, A Chadburn, E Cesarman, ... Journal of Clinical Oncology 23 (24), 5696-5704, 2005 | 187 | 2005 |
| Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial R Bellomo, LG Forni, LW Busse, MT McCurdy, KR Ham, DW Boldt, ... American journal of respiratory and critical care medicine 202 (9), 1253-1261, 2020 | 153 | 2020 |
| Treatment of cancer with 2-deoxyglucose G Tidmarsh US Patent 6,979,675, 2005 | 145 | 2005 |
| A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine TE Ciuleanu, AV Pavlovsky, G Bodoky, AM Garin, VK Langmuir, S Kroll, ... European journal of cancer 45 (9), 1589-1596, 2009 | 97 | 2009 |
| Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock R Bellomo, RG Wunderink, H Szerlip, SW English, LW Busse, AM Deane, ... Critical Care 24, 1-8, 2020 | 95 | 2020 |
| A new lymphocyte-specific gene which encodes a putative Ca2+-binding protein is not expressed in transformed T lymphocyte lines. J Jongstra, GF Tidmarsh, J Jongstra-Bilen, MM Davis Journal of immunology (Baltimore, Md.: 1950) 141 (11), 3999-4004, 1988 | 57 | 1988 |
| Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets GF Tidmarsh, S Heimfeld, CA Whitlock, IL Weissman, CE Müller-Sieburg Molecular and cellular biology 9 (6), 2665-2671, 1989 | 56 | 1989 |
| Methods for cancer imaging G Tidmarsh, M Matteucci US Patent 6,989,140, 2006 | 52 | 2006 |
| The early B lineage antigen BP-1 and the transformation-associated antigen 6C3 are on the same molecule. Q Wu, GF Tidmarsh, PA Welch, JH Pierce, IL Weissman, MD Cooper Journal of immunology (Baltimore, Md.: 1950) 143 (10), 3303-3308, 1989 | 48 | 1989 |
| Broad spectrum vasopressors: a new approach to the initial management of septic shock? LS Chawla, M Ostermann, L Forni, GF Tidmarsh Critical Care 23, 1-3, 2019 | 47 | 2019 |
| Normal thymic cortical epithelial cells developmentally regulate the expression of a B-lineage transformation-associated antigen B Adkins, GF Tidmarsh, IL Weissman Immunogenetics 27, 180-186, 1988 | 47 | 1988 |
| Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial KR Ham, DW Boldt, MT McCurdy, LW Busse, R Favory, MN Gong, ... Annals of Intensive Care 9, 1-10, 2019 | 45 | 2019 |